This project is designed to assess the utility of serial magnetic resonance (MR)-based volumetric measurements of the anterior temporal lobe (ATL) and hippocampal formation (HF) in aiding in the clinical diagnosis of dementia of the Alzheimer's type (DAT). This project will use MR volumes to provide predictive information on patients with a mild cognitive impairment as to which patients will progress to DAT and which will remain cognitively stable. Our previous work has shown that this MR-based volume measurement technique is useful in differentiating between DAT and normal controls; however, a single scan on patients in the mild cognitive impairment group is less definitive. We will draw upon previously funded projects to provide appropriately characterized patients for this project. The Mayo Clinic Alzheimer's Disease Patient Registry and the Alzheimer's Disease Center will provide the mechanism for recruitment, evaluation, and longitudinal assessment of patients and controls. An additional ongoing project funded by the NINDS will provide initial baseline MR scans on the patients and controls. Thus, the present application proposes to perform serial MR scans on three groups of individuals, DAT, mild cognitive impairment, and normal controls, to determine if volumetric changes in the ATL and HF will improve discrimination among the groups. We will be particularly interested in determining if volumetric changes of these structures help to determine which patients in the mild cognitive impairment group will ultimately progress to DAT and which patients will remain clinically stable. We will also correlate changes in the volumes of the ATL and HF with changes in clinical performance and cognitive function (particularly memory) over the course of the study. This proposal represents a unique opportunity at this point in time to maximally utilize existing resources to address important issues regarding the role of MR volume try in improving the early diagnosis of DAT.
| Botha, Hugo; Mantyh, William G; Murray, Melissa E et al. (2018) FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis. Brain 141:1201-1217 |
| Fatemi, Farzan; Kantarci, Kejal; Graff-Radford, Jonathan et al. (2018) Sex differences in cerebrovascular pathologies on FLAIR in cognitively unimpaired elderly. Neurology 90:e466-e473 |
| Utianski, Rene L; Whitwell, Jennifer L; Schwarz, Christopher G et al. (2018) Tau-PET imaging with [18F]AV-1451 in primary progressive apraxia of speech. Cortex 99:358-374 |
| Wennberg, Alexandra M V; Hagen, Clinton E; Machulda, Mary M et al. (2018) The association between peripheral total IGF-1, IGFBP-3, and IGF-1/IGFBP-3 and functional and cognitive outcomes in the Mayo Clinic Study of Aging. Neurobiol Aging 66:68-74 |
| Whitwell, Jennifer L; Graff-Radford, Jonathan; Tosakulwong, Nirubol et al. (2018) [18 F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease. Ann Neurol 83:248-257 |
| Botha, Hugo; Duffy, Joseph R; Whitwell, Jennifer L et al. (2018) Non-right handed primary progressive apraxia of speech. J Neurol Sci 390:246-254 |
| Wennberg, Alexandra M V; Lesnick, Timothy G; Schwarz, Christopher G et al. (2018) Longitudinal Association Between Brain Amyloid-Beta and Gait in the Mayo Clinic Study of Aging. J Gerontol A Biol Sci Med Sci 73:1244-1250 |
| Arnold Fiebelkorn, Catherine; Vemuri, Prashanthi; Rabinstein, Alejandro A et al. (2018) Frequency of Acute and Subacute Infarcts in a Population-Based Study. Mayo Clin Proc 93:300-306 |
| Ramanan, Vijay K; Przybelski, Scott A; Graff-Radford, Jonathan et al. (2018) Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older Adults. J Alzheimers Dis 65:1345-1352 |
| Utianski, R L; Whitwell, J L; Schwarz, C G et al. (2018) Tau uptake in agrammatic primary progressive aphasia with and without apraxia of speech. Eur J Neurol 25:1352-1357 |
Showing the most recent 10 out of 310 publications
